Preclinical Webinar on January 27: Understanding FDA Preclinical Animal Study Requirements – REGISTER

Video: Why Are Value Analysis Committees (VACs) Critical for Hospital Adoption?

Modern medical device setup with blue-covered equipment and multiple monitors, representing NAMSA's preclinical services.

Published:

August 7, 2025

In this expert-led video, Dawn Bitz, President of Lazzaro Medical, explains why value analysis committees (VACs) are essential for hospital adoption of new medical technologies. She shares how VACs evaluate innovation, clinical value, and pricing—and why early engagement and strategic planning can accelerate approval and purchasing decisions.

What You’ll Learn:

  • VAC Decision-Making: How VACs assess new technologies and determine adoption
  • Innovation Advantage: Why breakthrough products in stagnant categories gain traction faster
  • Pricing Strategy: How to communicate value and command sustainable margins

Whether you’re preparing to enter the hospital market or refining your product positioning, this video offers practical insights into navigating VACs successfully.

Let’s Talk About Your Project

Ask a question or request a meeting with a NAMSA expert to discuss your specific project. We will follow up as quickly as possible.

    By choosing to submit your information to contact NAMSA, you are providing NAMSA consent to process and store your information on the NAMSA Network. At any time, you can submit a request to withdraw your consent for the use of information provided by you. For additional information, please visit our Privacy Policy.